SCHEMBL1014845

SCHEMBL1014845

O=C(CN1CCc2nn(-c3ccc(C(F)(F)F)cc3)cc2C1)N1CCN(C2CCC2)CC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.41
HRH3 Q9Y5N1 4/20 0.40
CCR1 P32246 1/20 0.37
POLB P06746 1/20 0.37
IRAK4 Q9NWZ3 1/20 0.37
KCNH2 Q12809 2/20 0.36
MCHR1 Q99705 1/20 0.36
ME2 P23368 1/20 0.36
ME1 P48163 1/20 0.36
ME3 Q16798 1/20 0.36
AADAT Q8N5Z0 1/20 0.36
PARP1 P09874 1/20 0.36
CTSS P25774 2/20 0.35
KDM2B Q8NHM5 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CCR2 P41597 1/20 0.35
SCN9A Q15858 1/20 0.34
SCN10A Q9Y5Y9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1014525 0.90 HRH3 (0.40) PDK2HRH3KCNH2PARP1
SCHEMBL13748292 0.89 HRH3 (0.43) PDK2HRH3KCNH2PARP1KDM4E
SCHEMBL1017656 0.86 HTT (0.39) PDK2HRH3POLBPARP1ALDH1A1
SCHEMBL1016129 0.86 ALDH1A1 (0.47) PDK2HRH3KDM2BKDM4EALDH1A1
SCHEMBL1017564 0.84 HRH3 (0.39) PDK2HRH3KCNH2PARP1KDM4E
SCHEMBL1014999 0.83 HRH3 (0.38) HRH3KCNH2PARP1KDM4EALDH1A1
SCHEMBL4061339 0.81 HRH3 (0.37) PDK2HRH3KCNH2PARP1KDM4E
SCHEMBL13748854 0.81 SLC6A9 (0.43) HRH3KCNH2PARP1KDM4EALDH1A1
SCHEMBL1018826 0.81 KDM4E (0.39) HRH3KCNH2PARP1KDM4EALDH1A1
SCHEMBL13748931 0.80 PDK2 (0.36) PDK2HRH3IRAK4PARP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
EP-1998620-B1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES NEUROGEN CORP (US) 2011-01-12 EP disclosed
US-7795262-B2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION (US) 2010-09-14 US disclosed
US-7795262-B2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION (US) 2010-09-14 US disclosed
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION 2007-10-04 US disclosed
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues HRH3, HRH4, HRH1 PDK2 1557/4885HRH3 1/4885CCR1 349/4885
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 PDK2 1557/4885HRH3 1/4885CCR1 349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.